Claim OwnershipRheumMadness Rheumatology Podcast
Subscribed: 25Played: 223
Subscribe
© 2025 RheumMadness Rheumatology Podcast
Description
The RheumMadness podcast is part of a rheumatology learning initiative started with the assistance of the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award.
47 Episodes
Reverse
In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/r...
In this episode, we breakdown our reactions to the first round of RheumMadness 2025, plus we reveal which teams the participants liked the most in their brackets. To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness
Reminder to Submit your brackets by March 31, 2025 at 11:59pm ET! Link to the RheumMadness OnePager by Dr. Mithu Maheswaranathan (@MithuRheum) To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness
In this episode, the RheumMadness leadership team discusses our approach to RheumMadness bracketology, including our favorites, dark horses, and read on the Blue Ribbon Panel. Submit your brackets by March 31, 2025 at 11:59pm ET! To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ ...
In this episode, we introduce the rest of the Blue Ribbon Panel and interview our friends from NephMadness about their CAR-T region. Remember, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Blue Ribbon Panelists in this episode: Anastasiya (Stacy) Bagrova, MD completed internal medicine residency at Duke, rheumatology fellowship at the University of South Florida, and is now a ...
In this episode, we introduce 2 of our fantastic Blue Ribbon Panel members. Their full bios are listed below. You'll meet the rest of the panel in the next episode! Also, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Panelists in this podcast: Michele Meltzer, MD, MBE, is an Associate Professor of Medicine at Thomas Jefferson University in Philadelphia, Pennsylva...
In this episode we are joined by some amazing collaborators from the EMEUNET to talk about the STRAP trials. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship ProgramCD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship ProgramSTRAP trial, by the Emerging EULAR Network (EMEUNET)Links to theMednet.org Q&As about this region: In the treatment of lupus nephritis, which pa...
In this episode we discuss obinutuzumab for lupus nephritis and anti-CD19 CAR T Cell therapy for autoimmune rheumatic disease. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship ProgramCD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship ProgramSTRAP trial, by the Emerging EULAR Network (EMEUNET) Links to theMednet.org Q&As about this region: In the trea...
In this episode we present part 2 of our conversation about the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency ProgramSteroid dose in lupus nephritis, by the Washington University in St. Louis (WUSTL) Adult Rheumatology Fellowship ProgramSGCAPS prediction tool, by the Medical Co...
In this episode we dive into the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency ProgramSteroid dose in lupus nephritis, by the Washington University in St. Louis (WUSTL) Adult Rheumatology Fellowship ProgramSGCAPS prediction tool, by the Medical College of Wisconsin Adult Rheuma...
This episode contains part 2 of our conversation with Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, about the Cytokine Crushers region of RheumMadness 2025. In this episode, we focus specifically on the TYK2 in SLE and Oral Anti-IL23 teams. Links to the Cytokine Crushers Scouting Reports: Oral anti-IL23, by collaborating Chicago area rheumatology fellowship programs (Loyola, Northwestern, and the University of Chicago)Long-term outcomes of...
In this episode, we are joined by Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, to discuss the teams in the Cytokine Crushers region of RheumMadness 2025, the Innovation Invitational. This is part 1 of the conversation, where we go in depth about the long-term outcomes of anifrolumab in SLE study and give a primer about type 1/2 cytokines so you're ready to dig into the TYK2 in SLE and Oral Anti-IL23 studies. Join us again next week for part 2 of...
In this episode, we present the second part of our conversation with the authors of the scouting reports for the teams in the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational. Plus, we highlight Q&As from theMednet.org about the T'd Up T-Cells teams AND record an interview with Dr. Bill St. Clair, the first author of the phase 2 dazodalibep study. It's a long episode because there's so much content! Links to the Q&As from theMednet.org discussed in t...
In this episode, we dive in to the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational. This is the first of a two-part conversation with the authors of the scouting reports for the teams in this region. Check back next week to hear the rest of the conversation! To find the scouting reports and base articles discussed in this episode, head over to the scouting reports page of our website here: https://sites.duke.edu/rheummadness/bracket-and-scouting-reports/ ...
Welcome back to RheumMadness, the place for everyone who is crazy about rheumatology to connect, collaborate, compete, and learn together. The podcast took a hiatus in 2024 (hence why there are no episodes labeled season 4), but we we are thrilled to announce that the podcast is back for 2025 and beyond. In this episode, we explain some changes to the RheumMadness format and get you ready to experience everything this season has to offer. Find out more on the RheumMadness website: ...
In this episode, we are joined by two Blue Ribbon Panel members (Dr. Julie Paik and Dr. Angus Worthing) to recap the results of RheumMadness 2023. Plus, we hear from Dr. Nina Couette to review all the RheumMadness-related content on theMednet.org. Find out more on the RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/
For this episode, we invited anyone who wanted to join us for a live group discussion about the All Star Season. The result? Our first international guest on the podcast, two more fellow scouting report authors, and a ton of fun. Plus, hear Guy Katz make his picks (so you know who not to pick in the tournament), and hear a rundown of what we think the Blue Ribbon Panel might do. RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Mon...
In this episode, we discuss the right side of the bracket for RheumMadness 2023 with the scouting report authors. (Part 2 of 2) RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/
In this episode, we discuss the right side of the bracket for RheumMadness 2023 with the scouting report authors. (Part 1 of 2) RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/
In this episode, we discuss the left side of the bracket for RheumMadness 2023 with the scouting report authors. (Part 2 of 2) RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/
Comments
Download from Google Play
Download from App Store
United States